The molecular mechanisms underlying miR-181-mediated effect in malignant progression of breast cancer have been elucidated and associated with a novel target, the tumor suppressor SPRY4 (Protein sprouty homolog 4) [56]. The gene discussed is SPRY4; the disease is breast carcinoma.